Related Experiment Video
Updated: Mar 5, 2026

Gene Regulation and Targeted Therapy in Gastric Cancer Peritoneal Metastasis: Radiological Findings from Dual Energy CT and PET/CT
Published on: January 22, 2018
Immunotherapy for gastric cancers: emerging role and future perspectives
Marta Bonotto1,2, Silvio Ken Garattini1,2, Debora Basile1,2
1a Department Oncology , University Hospital of Udine , Udine , Italy.
Immunotherapy is transforming cancer care. For gastric cancer, identifying patients who will benefit from immunotherapy, particularly PD-1/PD-L1 inhibitors, is crucial for effective treatment.
Area of Science:
- Oncology
- Immunology
- Gastroenterology
Background:
- Immunotherapy is revolutionizing solid tumor treatment.
- Chemotherapy is the standard for advanced gastric cancer, but novel immunotherapies are emerging.
- Identifying patient subsets who benefit from immunotherapy is a key challenge.
Purpose of the Study:
- To summarize current knowledge on gastric cancer biology and clinical features.
- To explore whether specific molecular subsets of gastric cancer patients benefit more from immunotherapy.
- To review the mechanisms of immune evasion in cancer.
Main Methods:
- Comprehensive literature search on gastric cancer immunotherapy.
- Analysis of immune system regulation (activating/inhibitory signals).
- Review of clinical trial data for immunotherapy agents.
Main Results:
- Gastric cancer can evade immune responses.
- Anti-CTLA-4 antibodies show minimal activity.
- PD-1/PD-L1 inhibitors demonstrate growing efficacy in gastric cancer.
Conclusions:
- Harnessing the immune system is a promising frontier for gastric cancer treatment.
- Predictive factors are essential for optimizing immunotherapy use.
- Further research is needed to identify patient subgroups for immunotherapy.
More Related Videos
07:55Flow Cytometry-Based Isolation and Therapeutic Evaluation of Tumor-Infiltrating Lymphocytes in a Mouse Model of Pancreatic Cancer
Published on: January 17, 2025
07:47Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies
Published on: September 15, 2023
Related Concept Videos
Tumor Immunotherapy
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Targeted Cancer Therapies
There are several types of targeted therapies against...
Microorganisms in Medicine and Therapeutics
Mitogens and the Cell Cycle
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...